Business Context and Reporting Period
This Form 8-K Current Report was filed by Penumbra, Inc. on January 17, 2019. The filing discloses corporate governance changes, specifically the appointment of new independent directors and a restructuring of senior management roles within the North American sales organization.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Appointments: The Board appointed two new independent directors:
- Janet Leeds: Appointed as a Class I director effective immediately (January 17, 2019). Her term expires at the 2019 annual meeting.
- Surbhi Sarna: Appointed as a Class II director effective July 1, 2019. Her term expires at the 2020 annual meeting.
- Management Restructuring: Effective January 21, 2019, the role of President, North America was eliminated. Management of the North American sales team will be distributed among several current senior sales leaders reporting directly to the CEO and President.
- Role Continuity: Daniel Davis will continue as Chief Commercial Officer, focusing on strategic product and clinical benefit issues globally.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or specific risk factors. It notes that the new directors will receive compensation consistent with the Company's policy for non-employee directors and will enter into standard indemnification agreements. No transactions requiring disclosure under Item 404(a) of Regulation S-K were identified for the new directors.
Key Facts for Investor Verification
- Verify the specific qualifications and backgrounds of new directors Janet Leeds and Surbhi Sarna.
- Confirm the operational impact of eliminating the President, North America role and the new reporting structure for the sales team.
- Review the press release dated January 18, 2019 (Exhibit 99.1) for additional context on the appointments.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.